About
C3i is a CDMO for cell and gene therapies based in Montréal, Québec. It supports clients from process development through commercial manufacturing, laboratory testing, precision medicine, clinical research, and consulting for products intended for patients worldwide.
Services
Production
Develops, scales up, and manufactures cell and gene therapy processes through to commercial production.
Services de laboratoire
Provides assay development, qualification, validation, and quality control testing for cell and gene therapy products.
Médecine de précision
Provides companion diagnostics, therapeutic monitoring, and integrated patient support programs.
Recherche clinique
Supports clinical research activities for cell and gene therapy development.
Service de consultation
Offers project roadmaps, expert network access, funding support, process optimization, partner selection, and clinical trial preparation.
Contrôle de la qualité de la biofabrication
Performs testing for safety, purity, potency, and identity of cell and gene therapy products.
Diagnostic
Helps design, validate, and implement companion diagnostic tests for drugs, biomarkers, or diseases.
Suivi immunitaire
Measures immune reconstitution, persistence of transplanted cells, and related biomarkers for cell and gene therapies.
Capabilities
- Assays and studies
- ELISA
- NGS
- Endotoxin
- Gene expression
- ELISpot
- PCR
3 more
- Quantitative PCR
- Digital PCR
- Nanostring
- Therapeutic areas
- Cell therapy
- Gene therapy
- Diagnostics
Instruments and platforms
- NGS
- ELISpot
- ELISA
- PCR
- Quantitative PCR
- Digital PCR
- Nanostring
Modalities and species
- Modalities
- Cell therapy
- Gene editing
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CDMO
- Based in
- Montréal, QC, Canada